Remove topic biotech-spotlight
article thumbnail

Looking back at 2022: The top healthcare stories

Pharmaceutical Technology

Drug pricing was a hot-button topic, and William Newton found that while e-commerce chains could cut insulin prices , any major change won’t happen overnight. You can sign up for newsletters to never miss the latest news on pharma and biotech, clinical trial strategy and operations , and medical devices. See you in 2023!

Vaccines 122
article thumbnail

Early cell therapy successes start to turn the tide in lupus

Pharmaceutical Technology

In a field dominated by antibodies and small molecules, two cell-therapy based approaches have come under the spotlight for showing early signs of efficacy in treating lupus. Topic sponsors are not involved in the creation of editorial content. Cell & Gene Therapy coverage on Clinical Trials Arena is supported by Cytiva.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Upskilling in a digital health world

pharmaphorum

“We designed the programme to touch on the topics that we believe everyone in the industry should at least be aware of. This will allow participants to revisit and review key topics around the heavy demands of their professional responsibilities. Throughout the webinar, both speakers spotlighted the concept of value in education.

124
124
article thumbnail

Clive Dix: Rebuilding UK biotech

pharmaphorum

UK biotech guru Clive Dix has clinched some major deals with big pharma and biotech in the last 12 months, as CEO of C4X Discovery and as head of the UK vaccines taskforce. Dix has been a leading figure in UK biotech for the last 20 years – he co-founded Convergence Pharmaceuticals, which was acquired by Biogen in 2015.

article thumbnail

New €300m Angelini Ventures fund combines venture creation and direct investments to pave the way for healthcare transformation

pharmaphorum

Healthcare transformation has been a widely discussed topic for years, with many arguing for a more streamlined and tech- and data-driven approach to the industry that affects all people. The last few years have put a spotlight on mental health,” said Stupka in a statement.

105
105